Clinical Trials Browser

Congenital Abnormalities, Anemia, Aplastic, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Burkitt Lymphoma, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasms, Polycythemia Vera, Sezary Syndrome, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis, Intraocular Lymphoma

NCT03093870 2021-08-03

TreeTopp

Phase 2/3 Completed

151 enrolled 18 charts

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms

NCT02910063 2021-01-13

Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL

Phase 2/3 Completed

41 enrolled 18 charts

LymphoidOther hematologic neoplasm

Leukemia, Neoplasms, Recurrence, Lymphoma, B-Cell

NCT04546607 2020-09-16

Evaluation of Clinical Efficacy and Safety of Nuvastatic in Cancer Asthenia

Phase 2/3 Completed

110 enrolled

Asthenia, Neoplasms

NCT00123669 2020-07-22

Primary Progesterone Therapy for Operable Breast Cancer

Phase 2/3 Completed

1,000 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT01052051 2019-07-24

CAPS

Phase 2/3 Completed

2,303 enrolled

Tumor-Agnostic

Neoplasms

NCT01384877 2019-07-12

Subcutaneous Lidocaine For Cancer-Related Pain

Phase 2/3 Completed

33 enrolled 16 charts

Cancer Pain, Neoplasms, Pain

NCT01668459 2018-12-04

CabB1

Phase 2/3 Completed

20 enrolled

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms

NCT01458717 2018-05-02

Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer

Phase 2/3 Completed

58 enrolled

Gastrointestinal

Neoplasms, Pancreatic Neoplasms, Recurrence

NCT00999713 2018-03-16

CALIPSO

Phase 2/3 Completed

43 enrolled 15 charts

Neoplasms, Acute Lung Injury

NCT02116803 2018-03-01

An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective

Phase 2/3 Completed

12 enrolled 6 charts

Tumor-Agnostic

Neoplasms

NCT02388919 2017-09-18

ALTER0303

Phase 2/3 Completed

439 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01185470 2017-04-24

The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain

Phase 2/3 Completed

75 enrolled

Neoplasms, Chronic Pain

NCT00925899 2017-04-20

Melatonin for Fatigue and Other Symptoms in Patients With Advanced Cancer

Phase 2/3 Completed

72 enrolled 11 charts

Fatigue, Neoplasms

NCT00827554 2016-04-01

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

Phase 2/3 Completed

100 enrolled

Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms

NCT00393822 2014-07-15